Nicolò Azzola Guicciardi

ORCID: 0000-0002-5525-1638
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Infective Endocarditis Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Peptidase Inhibition and Analysis
  • Surgical Simulation and Training
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Metabolism and Genetic Disorders
  • Reconstructive Surgery and Microvascular Techniques
  • Cardiac tumors and thrombi
  • Aortic Disease and Treatment Approaches

Vita-Salute San Raffaele University
2022-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2022-2025

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2022-2025

IRCCS Ospedale San Raffaele
2023-2024

San Raffaele University of Rome
2024

Mylan (South Africa)
2024

Valve (United States)
2024

The COAPT Trial was the first ever to demonstrate a survival benefit in treating functional mitral regurgitation (FMR). That achieved through transcatheter repair selected patients. exact proportion of patients fulfilling selection criteria real-world is unknown.

10.1002/ccd.31124 article EN cc-by-nc-nd Catheterization and Cardiovascular Interventions 2024-06-24

ABSTRACT Background The COAPT Trial was the first ever to demonstrate a survival benefit in treating functional mitral regurgitation (FMR). That achieved through transcatheter repair selected patient. exact proportion of patients fulfilling selection criteria real-world is unknown. Objectives assess applicability and its impact on patients’ survival. Methods We assessed clinical data follow-up results all consecutive admitted for FMR at our Department between January 2016 May 2021 according...

10.1101/2024.02.27.24303471 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-02-29

Nowadays, the long-life management of patients with aortic stenosis has emerged as one most debated issues. Transcatheter valve replacement is more frequently performed in younger lower surgical risk, and also number valve-in-valve (ViV) procedures increased last few years. However, coronary obstruction dreadful complication related to this procedure. To prevent context transcatheter ViV implantation, BASILICA (bioprosthetic or native scallop intentional laceration iatrogenic artery...

10.1002/ccd.31121 article EN cc-by-nc Catheterization and Cardiovascular Interventions 2024-06-16

Abstract OBJECTIVES Aim of this study was to evaluate arrhythmic burden patients with Barlow’s disease and significant mitral regurgitation (MR) assess the impact repair on ventricular arrhythmias (VA) in group subjects. METHODS We prospectively included 88 consecutive referred our Institution from February 2021 May 2022. All enrolled underwent 24-h Holter monitoring before surgery. Sixty-three them completed 3 months echocardiographic follow-up. Significant defined as ≥1% premature beats/24...

10.1093/icvts/ivad073 article EN cc-by Interdisciplinary CardioVascular and Thoracic Surgery 2023-05-01

Abstract Background/Introduction Transcatheter mitral valve replacement (TMVR) is emerging in recent years as a promising tool to treat regurgitation, however its applicability the real world remains limited. Purpose The aim of study assess real-world screening success rate TMVR native anatomy and 1-year outcomes both accepted refused patients well clinical results. Methods Retrospective analysis was performed on all screened for at our Valve Center, eligible follow-up. In-hospital data...

10.1093/eurheartj/ehae666.2494 article EN European Heart Journal 2024-10-01

Abstract Background Atrioventricular (AV) conduction abnormalities remain one of the important unsolved issues with transcatheter aortic valve implantation (TAVI). To minimize trauma on fibers, we introduced a simple technique involving bending stiff guidewire wire at level arch to prevent and contact interventricular septum. Aim report for shape manipulation during TAVI evaluate its safety effectiveness in reducing need permanent pace–make after TAVI. Methods Results Before insertion into...

10.1093/eurheartjsupp/suae036.499 article EN other-oa European Heart Journal Supplements 2024-04-01

Abstract Background Some patients affected by mitral valve (MV) prolapse (MVP) are at higher risk of ventricular arrhythmias (VAs), but the underlying pathogenesis, as well effects surgery on VA, remain not fully understood. Mitral repair, however, represents a privileged point view to deepen understanding arrhythmogenesis in this context. Hence, we report an interesting case MV re-repair. Case summary A 52-year-old man was referred our institution for severe regurgitation (MR) due P2...

10.1093/ehjcr/ytae305 article EN cc-by European Heart Journal - Case Reports 2024-06-26

Despite its wide diffusion in surgical procedures, very few experiences are reported so far about the possible applications of remote proctoring (RP) structural heart interventions.

10.1002/ccd.31187 article EN Catheterization and Cardiovascular Interventions 2024-08-17

Background: Several surgical techniques have been proposed over the years to treat aortic arch pathology, confirming complexity of this disease. Our conventional approach is «debranch-first technique» combined frozen elephant trunk procedure (FET). In addition, an extra- anatomical bypass between left common carotid artery and subclavian (CSB) performed prior main surgery. The aim study was investigate early midterm results two-step-based procedure. Methods: Between 2012 2024, 87 patients...

10.2459/01.jcm.0001096216.75187.0a article EN Journal of Cardiovascular Medicine 2024-11-01

Abstract Background Barlow’s disease is associated with malignant ventricular arrhythmias (VA) and sudden cardiac death. No definitive data are available on baseline arrhythmic burden evolution of VA in pts undergoing mitral surgery for concomitant severe regurgitation (MR), therefore we started a prospective, single–center study these two aims. Materials & Methods From February 2021 to May 2022, 88 consecutive MR were admitted our Institution surgical treatment prospectively enrolled...

10.1093/eurheartjsupp/suad111.135 article EN European Heart Journal Supplements 2023-05-01
Coming Soon ...